Breast implant-associated anaplastic large cell lymphoma and breast implant illness have prompted recalls of implants.

Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks.

Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key.

Many devices in current use were marketed before manufacturers were required to demonstrate safety and effectiveness.

Dr Donna-Bea Tillman joins Ethics Talk to discuss her article: "What Should the Public Know About Implantable Material and Device Innovation in the US?"

Both physicians and pharmacists have responsibilities to ensure that opioids are prescribed and dispensed for legitimate medical purposes and to meet legal requirements.

Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key.

Label analysis is key to educating patients about risks of vitamin A-containing supplements.

Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians.

Clinicians’ racial biases undermine the quality of Black persons’ health care experiences and pave a reliable path to health care-induced harm.